Perfusion Systems Market Outlook To 2024: Key Technology Categories (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Organ Type (Kidney, Heart, Lungs, Liver), Regional Segmentation, Competitive Dynamics, M&A Insights, Pricing Analysis (OPP, IPP, RAP), And Segment Forecast

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The global perfusion systems market was valued at $79.7mn in 2016 and is anticipated to reach over $148.4mn by 2024.The perfusion systems market is anticipated to witness lucrative growth due to the growing prevalence of chronic diseases, rising demand for organ transplantation, growing geriatric population and technological advancements in organ preservation and transportation.

 

The rise in kidney failure due to obesity, diabetes, and high blood pressure is amongst the key factors driving the demand for transplantation. The American Kidney Fund estimates that 44% of all new kidney failure cases are due to diabetes, and 28.4% cases are due to high blood pressure. In 2015, the International Diabetes Federation (IDF) estimated that globally, over 400 million adults had diabetes and by 2040, more than 642 million adults are expected to suffer from diabetes. The growing prevalence of obesity, diabetes and hypertension are anticipated to strongly drive the demand for perfusion systems over the forecast period.

 

The waiting list for organ transplantation is growing rapidly, as more number of people are suffering from end-stage cardiovascular and kidney diseases. The lack of proper preservation technologies is resulting in high failure rate and wastage of resources. Traditionally, techniques such as Static Cold Storage (SCS) and Machine Perfusion (MP) were used for organ preservation. Moreover, to overcome the inefficiencies in preserving high-risk organs, Normothermic Machine Perfusion (NMP) is being adopted widely.

 

Perfusion Systems Market 2024

 

North America has a significantly higher base of geriatric population, suffering from various end-stage chronic conditions. The shortage of organ donors and inefficiency in preservation are a major concern to the government and healthcare providers. The Administration of Aging (AoA) estimates in the U.S., suggest that there are over 46.2 million people aged 65 and above, and majority of these people suffer from at least one chronic disease which eventually leads to organ failure or organ damage.  The rise in demand for organ transplantation is anticipated to reinforce market growth over the forecast period positively.

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Technology and Products”

 

Estimated Average perfusion system cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model. The prices of these systems are in the range of USD 10,000 to USD 100,000 and above depending on the technology, lifespan of the system and ability to preserve high-risk organs. The value or return on investment of these products is calculated based on an average lifespan of 10 years, which include the cost of consumables, accessories maintenance costs and the number of organs serviced during the period.

 

Perfusion Systems Market by “Technology”

 

Based on Technology, the market is categorized as hypothermic and normothermic. The hypothermic machine perfusion technology is used since the 1960’s and its major application areas include neurosurgery, cardiovascular surgery, and trauma care. The process involves the lowering of organ temperature to arrest the metabolic activities, decrease oxygen and substrate demand by the tissues and cells. Moreover, hypothermic machine perfusion of liver enables the continuous flow of metabolic substrates, antioxidants, and helps in flushing out toxins, cytokines and proteins from the liver.

 

However, normothermic machine perfusion is expected to emerge as the fastest growing due to its ability to overcome the problems faced due to cold storage for a longer duration. This technology can be used in in-situ and ex-situ perfusion techniques, and the results are more satisfactory compared to the hypothermic preservation. The warm blood preservation technique is gaining high demand for kidney and liver transplantation, and several R&D initiatives are in progress to extend the benefits of this technology for other organ transplantation.

 

Perfusion Systems Market by “Organ Type”

 

Based on the organ type, the market is segmented as kidney, heart, lungs, liver and others. Each organ requires specific preservation environment, and therefore specialized systems are used for each organ type. In 2016, kidney transplantation accounted for the majority share due to the high prevalence of chronic kidney failure. Few products which are used for machine perfusion of kidneys include WAVES RM3 by Waters Medical Systems and LifePort Kidney Transporter by Organ Recovery Systems Inc.

 

The growing prevalence of heart failure is expected to drive the future growth. The heart segment is expected to register the highest CAGR of over 8.2% over the forecast period.

 

Regional Segmentation

 

In 2016, North America held the maximum share due to the high disease burden, well-developed reimbursement framework, presence of advanced technology and a large number of patients registered for the organ transplantation. As per the latest data (May 21st 2017) by U.S. Organ Procurement and Transplantation Network, there are 117,960 patients who require an organ transplantation, and 76,016 people are on the active waiting list. Moreover, there were 11,061 transplantation procedures performed, however on an average 22 people die each die while waiting to receive a transplant. The chances of a heart failure and kidney failure increases drastically with the increase in age, and on an average every 10 minutes a new patient is added to the national transplant waiting list.

 

Asia Pacific is expected to outperform other regions by registering the fastest growth over the forecast period. The high population in the region, growing prevalence of chronic diseases and rising awareness about organ donation and transplantation are expected to drive the market growth. For instance, India is now the leading nation with the highest number of diabetic patients, with more than 69.2 million patients diagnosed. The high prevalence of diabetes is expected to increase heart failure and kidney failure rates significantly. Moreover, the government initiatives to promote national and regional organ transplantation networks is expected to reinforce growth prospects over the forecast period.

 

“Competitive Landscape” and “Merger & Acquisition Insights”

 

The perfusion systems market is dominated by players such as Organ Assist B.V.; TransMedics, Inc.; OrganOx Limited; Organ Transport Systems; Paragonix Technologies, Inc.; Organ Recovery Systems; XVIVO Perfusion AB; Waters Medical Systems; and Bridge to Life Ltd.  Most of the players operate exclusively in therapy areas such as Heart, kidney or liver, and are looking to expand through the acquisition route to bolster their portfolio and regional presence.

 

Market Segmentation

 

Perfusion Systems Market by Technology, (Revenue, Million, 2014 – 2024)

  • Hypothermic
  • Normothermic

Perfusion Systems Market by Organ Type, (Revenue, USD Million, 2014 – 2024)

  • Kidney
  • Heart
  • Lungs
  • Liver
  • Others

Perfusion Systems Market Regional Outlook, (Revenue, USD Million, 20124- 2024)

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain

Asia Pacific

  • Japan
  • China
  • India

Latin America

  • Brazil
  • Mexico
  • Columbia

Middle East and Africa

  • South Africa
  • Saudi Arabia

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Perfusion Systems Market Overview

  • Global Disease Landscape
  • Global Healthcare Expenditure

Chapter 4 Perfusion Systems Market Industry Outlook

  • Market Overview
  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Key Market Drivers
    • Rising Prevalence of Chronic Diseases
    • Increasing Geriatric Population
    • Growing demand for Organ Transplantation
  • Key Market Challenges
    • High Cost of Perfusion Systems
    • Shortage of Trained Professionals
  • Key Opportunities Prioritized
  • Industry Analysis - Porter’s
  • Perfusion Systems Market-PESTEL Analysis

Chapter 5: - Perfusion Systems Market by “Technology” (USD Million)

Perfusion Systems Market Landscape by Technology- 2016 & 2024
  • Hypothermic Machine Perfusion
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Normothermic Machine Perfusion
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 6: - Perfusion Systems Market by “Organ Type” (USD Million)

Perfusion Systems Market Landscape by End-Use- 2016 & 2024
  • Kidney
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Heart
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Lungs
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Liver
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Others
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 7: Regional Market Outlook

Perfusion Systems Market Landscape by Region- 2016
  • North America Market Landscape Analysis, 2016-2024 (USD Mn)
    • U.S. Market Landscape Analysis, 2016-2024
    • Canada Market Landscape Analysis-2016-2024
  • Europe Market Landscape Analysis, 2016-2024 (USD Mn)
    • UK Market Landscape Analysis, 2016-2024
    • Germany Market Landscape Analysis, 2016-2024
    • France Market Landscape Analysis, 2016-2024
    • Italy Market Landscape Analysis, 2016-2024
    • Spain Market Landscape Analysis, 2016-2024
  • Latin America Market Landscape Analysis, 2016-2024 (USD Mn)
    • Brazil Market Landscape Analysis, 2016-2024
    • Mexico Market Landscape Analysis, 2016-2024
    • Colombia Market Landscape Analysis, 2016-2024
  • Asia pacific Market Landscape Analysis, 2016-2024 (USD Mn)
    • Japan Market Landscape Analysis, 2016-2024
    • China Market Landscape Analysis, 2016-2024
    • India Market Landscape Analysis, 2016-2024
  • Middle East & Africa Market Landscape Analysis, 2014-2024 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2014-2024
    • South Africa Market Landscape Analysis, 2014-2024

Chapter 8: Pricing Analysis

Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2016
  • North America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • U.S. Pricing Analysis-2016
    • Canada Pricing Analysis-2016
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2016)
    • K Pricing Analysis-2016
    • Germany Pricing Analysis-2016
    • France Pricing Analysis-2016
    • Italy Pricing Analysis-2016
    • Spain Pricing Analysis-2016
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Brazil Pricing Analysis-2016
    • Mexico Pricing Analysis-2016
    • Colombia Pricing Analysis-2016
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Japan Pricing Analysis-2016
    • China Pricing Analysis-2016
    • India Pricing Analysis-2016
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Saudi Arabia Pricing Analysis-2016
    • South Africa Pricing Analysis-2016

Chapter 9: Perfusion Systems Pipeline Analysis

  • Executive Summary
  • Late Stage Pipeline analysis
  • Key R&D trends

Chapter 10: Perfusion Systems Merger &Acquisition Outlook

  • Factors driving M&A in smart syringes market
  • Key trends and future outlook

Chapter 11: Perfusion Systems Regulatory & Patent Outlook

  • Regulatory Landscape by Region (U.S., Europe, and RoW)
  • Patent Landscape by Region (U.S., Europe, and RoW)

Chapter 12: Competitive Landscape

  • Preservation Solutions Inc 
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Organ Recovery Systems, Inc
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Organ Transport Systems, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Paragonix Technologies, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • TransMedics, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • OrganOx Limited
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Preservation Solutions Inc
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Bridge to Life Ltd.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Wockhardt Ltd.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Siemens AG
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  List of Tables  
  • TABLE 1 Perfusion Systems Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2 Global Perfusion Systems Market, 2014 – 2024
  • TABLE 3 Global Perfusion Systems Market Analysis by Product-2016
  • TABLE 4 Global Perfusion Systems Market Analysis by Technology -2016
  • TABLE 5 Global Perfusion Systems Market Analysis by Application-2016
  • TABLE 7 Global Perfusion Systems Market Analysis by Geography-2016
  • TABLE 8 Global Perfusion Systems Market Analysis by Leading Brands-2016
  • TABLE 9 Perfusion Systems Market - Key market driver analysis
  • TABLE 10 Perfusion Systems Market - Key market restraint analysis
  • TABLE 11 North America Market Perfusion Systems Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 12U.S. Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 13 Canada Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 14 Europe Perfusion Systems Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 15 U.K Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 16 Germany Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 17 France Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 18 Italy Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 19 Spain Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 20 Latin America Perfusion Systems Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 21 Brazil Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 22 Mexico Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 20 Colombia Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 21 Asia pacific Perfusion Systems Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 22 Japan Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 23 China Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 24 India Perfusion Systems Market Landscape Analysis, 2016-2024
  • TABLE 25 North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 27 U.S. Pricing Analysis-2016
  • TABLE 28 Canada Pricing Analysis-2016
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 30 U.K Pricing Analysis-2016
  • TABLE 31 Germany Pricing Analysis-2016
  • TABLE 32 France Pricing Analysis-2016
  • TABLE 33 Italy Pricing Analysis-2016
  • TABLE 34 Spain Pricing Analysis-2016
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 36 Brazil Pricing Analysis-2016
  • TABLE 37 Mexico Pricing Analysis-2016
  • TABLE 38 Colombia Pricing Analysis-2016
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 40 Japan Pricing Analysis-2016
  • TABLE 41 China Pricing Analysis-2016
  • TABLE 42 India Pricing Analysis-2016
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 44 Saudi Arabia Pricing Analysis-2016
  • TABLE 45 South Africa Pricing Analysis-2016
  List of Figures  
  • 1 Perfusion Systems Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Perfusion Systems Market – PESTEL Analysis
  • 7 Perfusion Systems Market Share by Product Type, 2016 & 2024
  • 8 Perfusion Systems Market Share by Technology Type, 2016 & 2024
  • 9 Perfusion Systems Market Share by Application Type, 2016 & 2024
  • 10 Perfusion Systems Market Share by Region, 2016 & 2024

Key Insights Addressed:  

  • Defining market size from 2014 to 2016.
  • Estimating market growth till 2024 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:    
  • The global perfusion systems market was valued at $79.7mn in 2016 and is anticipated to reach over $148.4mn by 2024.
  • The rise in kidney failure due to obesity, diabetes, and high blood pressure is amongst the key factors driving the demand for transplantation.
  • Traditionally, techniques such as Static Cold Storage (SCS) and Machine Perfusion (MP) were used for organ preservation. Moreover, to overcome the inefficiencies in preserving high-risk organs, Normothermic Machine Perfusion (NMP) is being adopted widely.
  • The prices of these systems are in the range of USD 10,000 to USD 100,000 and above depending on the technology, lifespan of the system and ability to preserve high-risk organs.
  • The growing prevalence of heart failure is expected to drive the future growth. The heart segment is expected to register the highest CAGR of over 8.2% over the forecast period.
  • The perfusion systems market is dominated by players such as Organ Assist B.V.; TransMedics, Inc.; OrganOx Limited; Organ Transport Systems; Paragonix Technologies, Inc.; Organ Recovery Systems; XVIVO Perfusion AB; Waters Medical Systems; and Bridge to Life Ltd.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

  1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
  2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
  3. Need Gap Analysis- Defining the gap between our scope and availability of information.
  4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
  5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
  6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
  7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The global perfusion systems market was valued at $79.7mn in 2016 and is anticipated to reach over $148.4mn by 2024.The perfusion systems market is anticipated to witness lucrative growth due to the growing prevalence of chronic diseases, rising demand for organ transplantation, growing geriatric population and technological advancements in organ preservation and transportation.

 

The rise in kidney failure due to obesity, diabetes, and high blood pressure is amongst the key factors driving the demand for transplantation. The American Kidney Fund estimates that 44% of all new kidney failure cases are due to diabetes, and 28.4% cases are due to high blood pressure. In 2015, the International Diabetes Federation (IDF) estimated that globally, over 400 million adults had diabetes and by 2040, more than 642 million adults are expected to suffer from diabetes. The growing prevalence of obesity, diabetes and hypertension are anticipated to strongly drive the demand for perfusion systems over the forecast period.

 

The waiting list for organ transplantation is growing rapidly, as more number of people are suffering from end-stage cardiovascular and kidney diseases. The lack of proper preservation technologies is resulting in high failure rate and wastage of resources. Traditionally, techniques such as Static Cold Storage (SCS) and Machine Perfusion (MP) were used for organ preservation. Moreover, to overcome the inefficiencies in preserving high-risk organs, Normothermic Machine Perfusion (NMP) is being adopted widely.

 

Perfusion Systems Market 2024

 

North America has a significantly higher base of geriatric population, suffering from various end-stage chronic conditions. The shortage of organ donors and inefficiency in preservation are a major concern to the government and healthcare providers. The Administration of Aging (AoA) estimates in the U.S., suggest that there are over 46.2 million people aged 65 and above, and majority of these people suffer from at least one chronic disease which eventually leads to organ failure or organ damage.  The rise in demand for organ transplantation is anticipated to reinforce market growth over the forecast period positively.

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Technology and Products”

 

Estimated Average perfusion system cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model. The prices of these systems are in the range of USD 10,000 to USD 100,000 and above depending on the technology, lifespan of the system and ability to preserve high-risk organs. The value or return on investment of these products is calculated based on an average lifespan of 10 years, which include the cost of consumables, accessories maintenance costs and the number of organs serviced during the period.

 

Perfusion Systems Market by “Technology”

 

Based on Technology, the market is categorized as hypothermic and normothermic. The hypothermic machine perfusion technology is used since the 1960’s and its major application areas include neurosurgery, cardiovascular surgery, and trauma care. The process involves the lowering of organ temperature to arrest the metabolic activities, decrease oxygen and substrate demand by the tissues and cells. Moreover, hypothermic machine perfusion of liver enables the continuous flow of metabolic substrates, antioxidants, and helps in flushing out toxins, cytokines and proteins from the liver.

 

However, normothermic machine perfusion is expected to emerge as the fastest growing due to its ability to overcome the problems faced due to cold storage for a longer duration. This technology can be used in in-situ and ex-situ perfusion techniques, and the results are more satisfactory compared to the hypothermic preservation. The warm blood preservation technique is gaining high demand for kidney and liver transplantation, and several R&D initiatives are in progress to extend the benefits of this technology for other organ transplantation.

 

Perfusion Systems Market by “Organ Type”

 

Based on the organ type, the market is segmented as kidney, heart, lungs, liver and others. Each organ requires specific preservation environment, and therefore specialized systems are used for each organ type. In 2016, kidney transplantation accounted for the majority share due to the high prevalence of chronic kidney failure. Few products which are used for machine perfusion of kidneys include WAVES RM3 by Waters Medical Systems and LifePort Kidney Transporter by Organ Recovery Systems Inc.

 

The growing prevalence of heart failure is expected to drive the future growth. The heart segment is expected to register the highest CAGR of over 8.2% over the forecast period.

 

Regional Segmentation

 

In 2016, North America held the maximum share due to the high disease burden, well-developed reimbursement framework, presence of advanced technology and a large number of patients registered for the organ transplantation. As per the latest data (May 21st 2017) by U.S. Organ Procurement and Transplantation Network, there are 117,960 patients who require an organ transplantation, and 76,016 people are on the active waiting list. Moreover, there were 11,061 transplantation procedures performed, however on an average 22 people die each die while waiting to receive a transplant. The chances of a heart failure and kidney failure increases drastically with the increase in age, and on an average every 10 minutes a new patient is added to the national transplant waiting list.

 

Asia Pacific is expected to outperform other regions by registering the fastest growth over the forecast period. The high population in the region, growing prevalence of chronic diseases and rising awareness about organ donation and transplantation are expected to drive the market growth. For instance, India is now the leading nation with the highest number of diabetic patients, with more than 69.2 million patients diagnosed. The high prevalence of diabetes is expected to increase heart failure and kidney failure rates significantly. Moreover, the government initiatives to promote national and regional organ transplantation networks is expected to reinforce growth prospects over the forecast period.

 

“Competitive Landscape” and “Merger & Acquisition Insights”

 

The perfusion systems market is dominated by players such as Organ Assist B.V.; TransMedics, Inc.; OrganOx Limited; Organ Transport Systems; Paragonix Technologies, Inc.; Organ Recovery Systems; XVIVO Perfusion AB; Waters Medical Systems; and Bridge to Life Ltd.  Most of the players operate exclusively in therapy areas such as Heart, kidney or liver, and are looking to expand through the acquisition route to bolster their portfolio and regional presence.

 

Market Segmentation

 

Perfusion Systems Market by Technology, (Revenue, Million, 2014 – 2024)

  • Hypothermic
  • Normothermic

Perfusion Systems Market by Organ Type, (Revenue, USD Million, 2014 – 2024)

  • Kidney
  • Heart
  • Lungs
  • Liver
  • Others

Perfusion Systems Market Regional Outlook, (Revenue, USD Million, 20124- 2024)

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain

Asia Pacific

  • Japan
  • China
  • India

Latin America

  • Brazil
  • Mexico
  • Columbia

Middle East and Africa

  • South Africa
  • Saudi Arabia

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650